Ledger.Open graph →
SEC Form D · filed November 19, 2019

Lexaria Bioscience Corp

Offering
$2.4M
Sold
$493K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
KELOWNA, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

John Docherty · KELOWNA, British Columbia, CanadaExec · DirectorBrian Quigley · KELOWNA, British Columbia, CanadaDirectorAllan Spissinger · KELOWNA, British Columbia, CanadaExecTed Mckechnie · KELOWNA, British Columbia, CanadaDirectorNicholas Baxter · KELOWNA, British Columbia, CanadaDirectorChris Bunka · KELOWNA, British Columbia, CanadaExec · DirectorAndrew Salter · San Marino, CAExec · DirectorRobert Kennedy · Westport, CTExecBrian Laibow · Los Angeles, CADirectorJordan Mikes · Los Angeles, CADirectorThomas A. Davidson · Wes, CTExec · DirectorJohn Thomas · San Marino, CADirectorDavid Hansel · Red Bank, NJDirectorNanco Associates Associates LLC · Clarence, NYDirectorPaul S. Nanula · Clarence, NYDirectorAnthony Nanula · Clarence, NYExecLeonard J. Nobrega · Vail, COExec · DirectorAngel Vazquez · Miguel Hidalgo, CDMX, O5Exec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗